Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
10
4
0
0
AKERO THERAPEUTICSCS INC
Share · US00973Y1082 · AKRO · A2PLNP (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AKERO THERAPEUTICSCS INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 86,38 %
Shares Float 71,11 M
Shares Outstanding 82,32 M
Invested Funds
The following funds have invested in AKERO THERAPEUTICSCS INC:
Fund | Vol. in million 26,14 | Percentage (%) 0,06 % |
Company Profile for AKERO THERAPEUTICSCS INC Share
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
Company Data
Name AKERO THERAPEUTICSCS INC
Company Akero Therapeutics, Inc.
Symbol AKRO
Website
https://www.akerotx.com
Primary Exchange 
NASDAQ
NASDAQ
WKN A2PLNP
ISIN US00973Y1082
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Andrew Cheng
Market Capitalization 4 Mrd.
Country United States of America
Currency USD
Employees 0,1 T
Address 601 Gateway Boulevard, 94080 South San Francisco
IPO Date 2019-06-20
Ticker Symbols
| Name | Symbol |
|---|---|
| Düsseldorf | ATIRSD82.DUSB |
| Frankfurt | 0K4.F |
| NASDAQ | AKRO |
| Quotrix | ATIRSD82.DUSD |
More Shares
Investors who hold AKERO THERAPEUTICSCS INC also have the following shares in their portfolio:
